Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Cyclerion Therapeutics Inc (NASDAQ:CYCN) has entered into an exclusive, global license agreement with Akebia Therapeutics Inc (NASDAQ:AKBA) for the development and commercialization of praliciguat.
- Under the terms of the agreement, Akebia will be solely responsible for the research, development, and commercialization of praliciguat globally.
- Cyclerion is eligible to receive up to $225 million in pre-commercial milestones, including up to $15 million in the first 18 months.
- Total potential future milestone payments could result in up to $585M.
- Cyclerion is also eligible to receive tiered, sales-based royalties ranging from single-digit to high-teen percentages.
- Separately, Cyclerion has announced a private placement of approximately $18 million to a consortium of investors.
- The Company will sell around 5.7 million shares at $3.12 per share.
- "This capital, coupled with the praliciguat out-license announced today, reinforces our strategic focus in CNS and will accelerate the advancement of clinical studies for CY6463 and the further development of our next generation molecule, CY3018," said Peter Hecht, CEO.
- Price Action: CYCN stock is up 4.02% at $3.36, and AKBA shares up 0.45% at $3.35 during the market session on the last check Friday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!